First Experiences in Combination Therapy Using Olanzapine with SSRIs (Citalopram, Paroxetine) in Delusional Depression

Publisher： Karger

E-ISSN： 1423-0224|43|3|170-174

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.43, Iss.3, 2001-03, pp. : 170-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thyroid Parameters during Therapy with Zotepine in Delusional Depression

By  

Neuropsychobiology, Vol. 37, Iss. 2, 1998-04 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Evaluation of the Prophylactic Efficacy of Amitriptyline and Citalopram, Alone or in Combination, in Patients with Comorbidity of Depression, Migraine, and Tension-Type Headache

By  

Neuropsychobiology, Vol. 50, Iss. 4, 2004-11 ,pp. : 322-328

Karger

Access to resources Recommend Favorite

Differential Antidepressant Symptom Efficacy: Placebo-Controlled Comparisons of Duloxetine and SSRIs (Fluoxetine, Paroxetine, Escitalopram)

By  

Neuropsychobiology, Vol. 56, Iss. 2-3, 2007-11 ,pp. : 73-85

Karger

Access to resources Recommend Favorite

No Association of TPH1 218A/C Polymorphism with Treatment Response and Intolerance to SSRIs in Japanese Patients with Major Depression

By  

Neuropsychobiology, Vol. 56, Iss. 4, 2008-03 ,pp. : 167-171

Karger

Access to resources Recommend Favorite

Basal Prolactin Values Correlate with Response to Reboxetine Treatment in Major Depression, but Not with Response to Citalopram

By  

Neuropsychobiology, Vol. 51, Iss. 2, 2005-03 ,pp. : 67-71

Karger

Access to resources Recommend Favorite